Nicotinamide riboside kinase 2: A unique target for skeletal muscle and cardiometabolic diseases
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2024-12 · 1870 (8) · 167487
DOI: 10.1016/j.bbadis.2024.167487 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024-12. Verfasst von Firdos Ahmad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Group, Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates; Space M…. Hauptthemen laut MEDLINE: Muscle, Skeletal, Phosphotransferases (Alcohol Group Acceptor). Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: University of Sharjah.
Abstract (Originalsprache)
Myopathy leads to skeletal and cardiac muscle degeneration which is a major cause of physical disability and heart failure. Despite the therapeutic advancement the prevalence of particularly cardiac diseases is rising at an alarming rate and novel therapeutic targets are required. Nicotinamide riboside kinase-2 (NRK-2 or NMRK2) is a muscle-specific β1-integrin binding protein abundantly expressed in the skeletal muscle while only a trace amount is detected in the healthy cardiac muscle. The level in cardiac tissue is profoundly upregulated under pathogenic conditions such as ischemia and hypertension. NRK-2 was initially identified to regulate myoblast differentiation and to enhance the levels of NAD+, an important coenzyme that potentiates cellular energy production and stress resilience. Recent advancement has shown that NRK-2 critically regulates numerous cellular and molecular processes under pathogenic conditions to modulate the disease severity. Therefore, given its restricted expression in the cardiac and skeletal muscle, NRK-2 may serve as a unique therapeutic target. In this review, we provided a comprehensive overview of the diverse roles of NRK-2 played in different cardiac and muscular diseases and discussed the underlying molecular mechanisms in detail. Moreover, this review precisely examined how NRK-2 regulates metabolism in cardiac muscle, and how dysfunctional NRK-2 is associated with energetic deficit and impaired muscle function, manifesting various cardiac and skeletal muscle disease conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research Group, Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates; Space Medicine Group, Research Institute of Medical and Health Sciences, Univ…
Förderung
- University of Sharjah
Zitieren
APA
Ahmad, F., & Qaisar, R. (2024). Nicotinamide riboside kinase 2: A unique target for skeletal muscle and cardiometabolic diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1870(8), 167487. https://doi.org/10.1016/j.bbadis.2024.167487
Vancouver
Ahmad F, Qaisar R. Nicotinamide riboside kinase 2: A unique target for skeletal muscle and cardiometabolic diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2024;1870(8):167487. doi:10.1016/j.bbadis.2024.167487
BibTeX
@article{Ahmad2024,
author = {Ahmad, Firdos and Qaisar, Rizwan},
title = {Nicotinamide riboside kinase 2: A unique target for skeletal muscle and cardiometabolic diseases},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2024},
volume = {1870},
number = {8},
pages = {167487},
doi = {10.1016/j.bbadis.2024.167487}
}
EUVIMED